Early Insights from Commercialization of Gene Therapies in Europe

Early Insights from Commercialization of Gene Therapies in Europe

After years of research and development, gene therapies are now becoming a commercial reality with several products approved by European regulatory authorities [...]

Bibliographic Details
Main Authors: Nicolas Touchot, Mathias Flume
Format: Article
Language:English
Published: MDPI AG 2017-02-01
Series:Genes
Subjects:
gene therapies
payers
market access
Glybera
Strimvelis
Imlygic
reimbursement
commercialization
Online Access:http://www.mdpi.com/2073-4425/8/2/78
Description
Summary:After years of research and development, gene therapies are now becoming a commercial reality with several products approved by European regulatory authorities [...]
ISSN:2073-4425

Similar Items